High tumor tissue expression of OSM (p < 0.001, Figure 1A) and IL-6 (p < 0.001, Figure 1B) each independently correlated with a significant decrease in invasive breast cancer patient survival. The gene discussed is IL6; the disease is invasive breast carcinoma.